Risedronato Semanal Aristo

Medicinal product

(Invented) name

Risedronato Semanal Aristo

Active substance (s)

Natrio rizedronatas

Strength

35 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M05BA07, Risedronic acid

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-08-18

Date of renewal

Documents

2773_Risedronato Semanal Aristo 35mg_pl_deng_tab_PL_2025-08-18.docx

2773_Risedronato Semanal Aristo 35mg_pl_deng_tab_PZ_2025-08-18.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Natrio rizedronatas	35 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118320	104425	1104425	lizdinė plokštelė	N4		Receptinis	LT/L/25/2773/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-08-18	Registruotas